Gonadotropin-Releasing Hormone (GnRH)-Antagonist Therapy in Rheumatoid Arthritis
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and efficacy of gonadotropin-releasing
hormone (GnRH) antagonist therapy versus placebo in patients with moderate to severe
rheumatoid arthritis.
Phase:
Phase 2
Details
Lead Sponsor:
Betanien Hospital
Collaborators:
Norwegian Foundation for Health and Rehabilitation University of Oslo